The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

State of West Virginia ex rel. E. I. du Pont de Nemours and Company v. Perrine
The firm served as appellate counsel for a trial team representing DuPont in a major medical monitoring class-action in West Virginia and briefed a more
Leather Indus., et al. v. EPA
The firm served as lead counsel in representing the city of Pueblo, Colorado in a successful challenge to parts of an EPA rule on sludge more
Negotiated rights of way and siding agreements for one of the nation’s premier transportation companies
Negotiated rights of way and siding agreements for one of the nation’s premier transportation companies and others in connection with construction of more
Damage claims of trust funds, lands and resources for a tribal community
Serves as lead counsel, representing a tribal community’s claims for damages for mismanagement of tribal trust funds, lands and resources the U.S. more